In 2013, Indonesias population stood at 251 million, up from 238 million in 2008. The major factors that contributed to the growth in the population are an increase in net migration and a drop in the death rate. The countrys pharmaceutical market was estimated to have been worth $5 billion in 2013 and is expected to reach $9.9 billion by 2020 at a projected Compound Annual Growth Rate (CAGR) of 10.2%. In 2010, according to US Commercial Service estimates, the countrys medical device market was worth $573m.

1. CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia
Summary
GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia. It is
an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Indonesia, identifying key trends in the healthcare
market and providing insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides
valuable insights into the trends and segmentation of the pharmaceutical and medical devices market. It is built using data and information sourced from
proprietary databases, secondary research and in-house analysis by GlobalDatas team of industry experts.
In 2013, Indonesias population stood at 251 million, up from 238 million in 2008. The major factors that contributed to the growth in the population are an
increase in net migration and a drop in the death rate. The countrys pharmaceutical market was estimated to have been worth $5 billion in 2013 and is expected to
reach $9.9 billion by 2020 at a projected Compound Annual Growth Rate (CAGR) of 10.2%. In 2010, according to US Commercial Service estimates, the
countrys medical device market was worth $573m.
The positive trends in the Indonesian healthcare market can primarily be attributed to -
- Increasing coverage of healthcare insurance
- Improved access to healthcare facilities
Scope
- Overview of the pharmaceutical and medical device markets, including size, segmentation and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical and medical device markets: PT Kalbe Farma Tbk, PT Tempo Scan Pacific Tbk, Kimia
Farma, PT Darya-Varia Laboratoria Tbk and PT Indofarma Tbk
- An insightful review of the reimbursement and regulatory landscape, covering the healthcare reimbursement process, regulatory agencies and the approval
processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure and healthcare
expenditureAn overview of the opportunities for and challenges to growth in the healthcare market
Reasons to buy
The report will enhance your decision-making capability by allowing you to -
- Develop business strategies through an understanding of the trends shaping and driving the healthcare market
- Drive revenue by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical device market segments and companies
likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment
and strategic partnership
- Identify, understand and capitalize on the opportunities and challenges in the healthcare market
1 Table Of Contents
1 Table Of Contents 6
1.1 List Of Tables 9
1.2 List Of Figures 12
2 Introduction 16
2.1 Globaldata Report Guidance 16
3 Overview Of Pharmaceutical And Medical Device Markets 17
3.1 Pharmaceutical Market 17
3.1.1 Market Overview 17
3.1.2 Supply Channels 20
3.1.3 Market Segments 22
3.1.4 Major Drug Classes 26
3.1.5 Major Players 33
3.2 Medical Device Market 53
3.2.1 Market Overview 53
3.3 Market Drivers And Barriers 55
3.3.1 Drivers 55
3.3.2 Barriers 56
4 Market Access 59
4.1 Reimbursement And Payer Landscape 59
4.1.1 Overview Of Healthcare System 59
4.1.2 Reimbursement Process 60
4.1.3 Overview Of Insurance Providers 62
4.1.4 Patient Share Of Healthcare Expenditure 65
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia

2. 4.1.5 Healthcare Price Trends 66
4.1.6 Pricing Policies 67
4.2 Regulatory Landscape 68
4.2.1 Overview Of Regulatory Agencies 68
4.2.2 Market Authorization Procedure For Pharmaceutical Products 69
4.2.3 New Medical Device Approval Process 73
4.2.4 Licensing Process For Pharmaceutical And Medical Device Manufacturing 75
4.2.5 Licensing Process For Pharmaceutical Exports And Imports 76
4.2.6 Intellectual Property Rights 77
4.2.7 Clinical Trial Regulations 81
4.2.8 Pharmaceutical Advertising Regulations 82
4.2.9 Pharmacy Regulations 83
4.2.10 Labeling And Packaging Regulations 83
5 Country Analysis 85
5.1 Political Environment 85
5.1.1 Political Structure 85
5.1.2 Analysis Of The Current Political Environment 86
5.1.3 Healthcare Policy Initiatives 87
5.2 Economic Landscape 89
5.3 Economic Indicators 92
5.3.1 Gross Domestic Product 92
5.3.2 Gross National Income 96
5.3.3 Inflation 98
5.3.4 Currency Exchange Rate 101
5.3.5 Foreign Direct Investment 102
5.3.6 Foreign Exchange Reserves 104
5.3.7 Trade Balance 105
5.3.8 Government Structural Balance 107
5.3.9 Government Gross Debt 108
5.3.10 Major Industries 110
5.4 Demographics 112
5.4.1 Population 112
5.4.2 Education And Literacy 126
5.4.3 Employment 129
5.4.4 Disease Burden 130
5.5 Healthcare Infrastructure 133
5.5.2 Healthcare Parameters 138
5.5.3 Environmental Health 140
5.5.4 Healthcare Personnel 145
5.6 Healthcare Expenditure 148
5.6.1 Overview Of Healthcare Expenditure 148
5.6.2 Major Components Of Healthcare Expenditure 150
5.6.3 Healthcare Expenditure Distribution 151
5.7 Trade Associations 153
5.7.1 International Pharmaceutical Manufacturers Group 153
5.7.2 Indonesia Pharmaceutical Association 153
5.7.3 Indonesia Medical Association 153
5.8 Trade Fairs 153
6 Opportunities And Challenges 155
6.1 Opportunities 155
6.2 Challenges 157
7 Appendix 159
7.1 Abbreviations 159
7.2 Bibliography 161
7.3 Research Methodology 169
7.3.1 Coverage 170
7.3.2 Secondary Research 170
7.3.3 Forecasts 171
7.3.4 Expert Panel 171
7.4 Disclaimer 171
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia

3. 90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia